Briviact (UCB, Inc.)
Welcome to the PulseAid listing for the Briviact drug offered from UCB, Inc.. This Epoxide Hydrolase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | UCB, Inc. |
| NON-PROPRIETARY NAME: | brivaracetam |
| SUBSTANCE NAME: | BRIVARACETAM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Epoxide Hydrolase Inhibitors [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SUSPENSION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2016-05-12 |
| END MARKETING DATE: | 0000-00-00 |
Briviact HUMAN PRESCRIPTION DRUG Details:
| Item Description | Briviact from UCB, Inc. |
| LABELER NAME: | UCB, Inc. |
| DEA SCHEDULE: | CV
|
| ACTIVE STRENGTH: | 50(mg/5mL) |
| START MARKETING DATE: | 2016-05-12 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 50474-970_7d59b2b8-0e38-4a6a-8e63-488ca47a0288 |
| PRODUCT NDC: | 50474-970 |
| APPLICATION NUMBER: | NDA205837 |
Other BRIVARACETAM Pharmaceutical Manufacturers / Labelers:
